25th Annual OptumHealth Education National Conference
In-Person Event
Oct 05 - 07, 2016
Minneapolis, Minnesota, USASpeakers
OVERVIEW
25th Annual OptumHealth Education National Conference is organized by OptumHealth Education and would be held during Oct 5 - 7, 2016 at Minneapolis Marriott City Center, Minneapolis, Minnesota, united States of America.
The target audience for this medical event basically for health care professionals, Medical Directors/Physicians/PAs, Case Managers, Managed Care Nurses, Nurses/Oncology Nurses/Transplant Nurses, Nurse Practitioners, Pharmacists/Pharmacy Technicians, Transplant Coordinators, Hematopoietic Transplant Coordinators, Medical Management Staff, Reinsurance Managers, Utilization Review Staff. This CME conference has been approved with 13.75 AMA PRA Category 1 Credits.
Conference educational objectives :
After completion of this activity, the participant should be able to:
• Explore advances in medical and surgical management of diabetes, including DPP-4 and SGLT2 inhibitors, SGLT1 receptor agonists, pancreas and islet transplant, and the utility of stem-cell-derived beta cells for future treatment of diabetes.
• Recognize advanced treatment approaches for HIV and hepatitis C and acknowledge how these infectious diseases continue to represent a significant public health risk.
• Identify transplant-recipient- and caregiver-reported challenges with regard to hematopoietic stem cell transplant and coordination of care for this population.
• Discuss current research and best-practice standards for optimal management of heart failure, and debate the pros and cons of heart transplant versus ventricular assist device for patients over 70 years of age.
• Describe the various types of cancer immunotherapy to include monoclonal antibodies, cancer vaccines, chimeric-antigen receptor (CAR) T-cell therapy, and immune-checkpoint inhibitors, and outline their clinical applications.
The target audience for this medical event basically for health care professionals, Medical Directors/Physicians/PAs, Case Managers, Managed Care Nurses, Nurses/Oncology Nurses/Transplant Nurses, Nurse Practitioners, Pharmacists/Pharmacy Technicians, Transplant Coordinators, Hematopoietic Transplant Coordinators, Medical Management Staff, Reinsurance Managers, Utilization Review Staff. This CME conference has been approved with 13.75 AMA PRA Category 1 Credits.
Conference educational objectives :
After completion of this activity, the participant should be able to:
• Explore advances in medical and surgical management of diabetes, including DPP-4 and SGLT2 inhibitors, SGLT1 receptor agonists, pancreas and islet transplant, and the utility of stem-cell-derived beta cells for future treatment of diabetes.
• Recognize advanced treatment approaches for HIV and hepatitis C and acknowledge how these infectious diseases continue to represent a significant public health risk.
• Identify transplant-recipient- and caregiver-reported challenges with regard to hematopoietic stem cell transplant and coordination of care for this population.
• Discuss current research and best-practice standards for optimal management of heart failure, and debate the pros and cons of heart transplant versus ventricular assist device for patients over 70 years of age.
• Describe the various types of cancer immunotherapy to include monoclonal antibodies, cancer vaccines, chimeric-antigen receptor (CAR) T-cell therapy, and immune-checkpoint inhibitors, and outline their clinical applications.
KEY DATES
05 Oct, 2016
Event Start Date
07 Oct, 2016
Event End Date
SPECIALITIES
Healthcare TechnologySUGGESTED HOTELS
CONFERENCE VENUE
Minneapolis Marriott City CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links